about
A single dose of methadone inhibits cytochrome P-4503A activity in healthy volunteers as assessed by the urinary cortisol ratioInteractions between recreational drugs and antiretroviral agents.Efflux transporters- and cytochrome P-450-mediated interactions between drugs of abuse and antiretrovirals.Drug interactions in the management of HIV infection.Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy.Pharmacokinetic interactions between HIV antiretroviral therapy and drugs used to treat opioid dependence.Rapid clinical induction of hepatic cytochrome P4502B6 activity by ritonavirMechanism of ritonavir changes in methadone pharmacokinetics and pharmacodynamics: II. Ritonavir effects on CYP3A and P-glycoprotein activities.Mechanism of ritonavir changes in methadone pharmacokinetics and pharmacodynamics: I. Evidence against CYP3A mediation of methadone clearance.The role of cytochrome P450 in antiretroviral drug interactions.Interindividual variability of methadone response: impact of genetic polymorphism.Induction effects of ritonavir: implications for drug interactions.Methadone: a review of drug-drug and pathophysiological interactions.A review of drug-drug interactions in older HIV-infected patients.Pharmacokinetics and pharmacodynamics of methadone enantiomers after coadministration with fosamprenavir-ritonavir in opioid-dependent subjects.Gas chromatography-mass spectrometry measurement of 6beta-OH-cortisol/cortisol ratio in human urine: a specific marker of enzymatic induction.Pharmacokinetics and pharmacodynamics of methadone enantiomers after coadministration with amprenavir in opioid-dependent subjects.Effect of tenofovir disoproxil fumarate on the pharmacokinetics and pharmacodynamics of total, R-, and S-methadone.
P2860
Q28363552-B53785DC-8A70-425A-BE75-D12F6BA64CD4Q34874414-B7251A5D-C5B2-466D-9071-C7EAE0BE2792Q35000765-F6935213-3E07-428A-8ECD-A6E2F79D070DQ36066083-30EE48F5-3188-4F16-832B-85BDBC4AC04CQ36273367-5AD0FEE6-75EA-4715-9BE3-201153181E55Q36543096-555AED7B-998B-463C-9790-AE61117380EBQ36593838-F9441165-3CC7-488C-915E-40D166C0AD07Q36641870-C7880B6F-8263-43C4-BF44-B67169E84AFDQ36641884-C00B1336-73B6-4E7A-B5A5-76251AD2929AQ36909336-D1123F0C-0BA0-4BEC-8582-D475FAD46E06Q37142009-95C86BDB-9DCE-4CF1-A346-A28D19647FE6Q37199533-311293D2-B8EE-4B04-A9D7-ABADB8E77A13Q37950478-2BEAA64E-F816-46BE-AD8A-F1128FE6F513Q41996857-06BA14B8-0076-4DF1-B6D8-DA38750DC5A1Q42660244-C9FEC8B5-55F1-48EC-9454-B6AC81BEC065Q43858767-4DD7CB46-5844-40FF-8DEF-748D483488D9Q44346900-54E6AD26-C506-437A-956C-6552417F5F4BQ45037771-64C08C0F-1B47-4785-AAF3-15A27A8DABF8
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Decreased methadone effect after ritonavir initiation
@ast
Decreased methadone effect after ritonavir initiation
@en
Decreased methadone effect after ritonavir initiation
@nl
type
label
Decreased methadone effect after ritonavir initiation
@ast
Decreased methadone effect after ritonavir initiation
@en
Decreased methadone effect after ritonavir initiation
@nl
prefLabel
Decreased methadone effect after ritonavir initiation
@ast
Decreased methadone effect after ritonavir initiation
@en
Decreased methadone effect after ritonavir initiation
@nl
P1433
P1476
Decreased methadone effect after ritonavir initiation
@en
P2093
A D Erickson
S M Geletko
P356
10.1592/PHCO.20.1.93.34654
P407
P577
2000-01-01T00:00:00Z